The tissue analysis device maker, a spinout from Stanford University, has selected the Nasdaq Global Select Market for its initial public offering.

Akoya Biosciences, a US-based tissue analysis technology developer spun out of Stanford University, has filed to raise $115m in an initial public offering on the Nasdaq Global Select Market.
Founded in 2015, Akoya has built a tissue analysis technology platform called Codex which allows users to analyse tissue cells and create images of more than 40 protein markers within them at a single-cell resolution.
The technology was developed in a laboratory at Stanford University overseen by Akoya…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?